Ammune.ai

Ammune.ai, founded in 2016 in Be’er Sheva, Israel as L7 Defense, is an API and AI security vendor whose AMMUNE platform uses self-learning, signature-free detection to identify and block API-borne attacks, bot abuse, and application-layer (Layer 7) DDoS traffic in real time. The company rebranded from L7 Defense to Ammune.ai as its focus broadened from application-layer DDoS mitigation specifically into wider API and AI-workload protection, describing its approach as an "immune system" that autonomously learns normal API traffic behavior and flags anomalous, previously unseen attack patterns without relying on static rules or signatures.

The company partnered with Check Point Software to integrate applicative-DDoS protection into Check Point’s portfolio, one of its clearest pieces of independently verifiable market traction. Investors including Quick Heal and TRUMPF have backed the company through a seed and Series A round totaling roughly $5.3 million, per Crunchbase. Ammune.ai remains a very small team — about a dozen employees as of 2026 — reflecting an early-stage, narrowly focused vendor rather than a broad platform player.

Marketing claims of being "trusted by" large numbers of customers, along with a featured Envato testimonial, appear on the company’s site without detailed case-study substantiation. No independent penetration test, MITRE ATT&CK evaluation, or analyst-lab result for the AMMUNE engine was found publicly, so efficacy claims beyond the Check Point integration should be treated as vendor-sourced.